A few opinions from our AOL boards... Subj: VIMRX/Baxter Joint VentureDate: 04 Jun 1997 12:31:34 EDTFrom: Jim6317Message-ID: <19970604163100.MAA04107@ladder02.news.aol.com>I'm a shareholder of VIMRX Pharm (VMRX). Rumor has it they are in discussions with quite a few pharm co's in a JV for their Oligozyme technology developed by a subsidiary -Innovir (INVR). Baxter is said to be the front runner. Anything heard on this end?========Subj: Strong Buy RecommendationDate: 23 May 1997 13:37:13 EDTFrom: TMF ElwoodMessage-ID: <19970523173700.NAA06431@ladder01.news.aol.com>CS First Boston said it initiated coverage of Baxter International Inc <BAX.N> with a strong buy recommendation. =======Subj: Re: Re:Blood SubstituteDate: Sat, 19 Apr 1997 10:18:23 ESTFrom: LewA838328Message-ID: <19970419141800.KAA28103@ladder01.news.aol.com>According to Value Line the blood substitute poduct (called HemAssist) will go on sale in Europe in early 98. and in the US about a year later. Value Line sales estimates for 98 include 100 million for the blood substitute product! Its potential world market probably approaches 3 Billion.LA
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analys